GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Quantum-Si Inc (NAS:QSI) » Definitions » Cash per Share

QSI (Quantum-Si) Cash per Share : $1.38 (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Quantum-Si Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Quantum-Si's Cash per Share for the quarter that ended in Sep. 2024 was $1.38.

Quantum-Si Cash per Share Historical Data

The historical data trend for Quantum-Si's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum-Si Cash per Share Chart

Quantum-Si Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Cash per Share
- 0.27 3.42 2.51 1.82

Quantum-Si Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.94 1.82 1.66 1.53 1.38

Quantum-Si Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Quantum-Si's Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=257.736/141.77
=1.82

Quantum-Si's Cash per Share for the quarter that ended in Sep. 2024 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=196.344/142.71
=1.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quantum-Si  (NAS:QSI) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Quantum-Si Cash per Share Related Terms

Thank you for viewing the detailed overview of Quantum-Si's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Quantum-Si Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Quantum-Si Inc (NAS:QSI) » Definitions » Cash per Share
Comparable Companies
GRTS OBIO BIVI GLUE AKBA ALLK OTLK ATXS TCRX ALVR OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
29 Business Park Drive, Branford, CT, USA, 06405
Website
https://www.quantum-si.com
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.
Executives
Christian Lapointe officer: General Counsel & Corp. Secr. C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Jeffry R. Keyes officer: Chief Financial Officer 13950 STOWE DRIVE, POWAY CA 92064-8803
Jeffrey Alan Hawkins director, officer: Chief Executive Officer 5964 LA PLACE COURT, CARLSBAD CA 92008
Grace Johnston officer: Chief Commercial Officer C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Amir Jafri director C/O QUANTUM-SI INCORPORATED, 29 BUSINESS PARK DR., BRANFORD CT 06405
John P. Kenny director 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Scott Mendel director 5964 LA PLACE COURT, ADDRESS 2, CARLSBAD CA 92008
Kevin Rakin director, officer: Chairman and CEO 36 CHURCH LANE, WESTPORT CT 06880
Vikram Bajaj director 600 MONTGOMERY STREET, SUITE 4500, SAN FRANCISCO CA 94111
Jonathan M Rothberg director, 10 percent owner C/O BUTTERFLY NETWORK, INC., 530 OLD WHITFIELD ST., GUILFORD CT 06437
Matthew Dyer officer: Chief Business Officer C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Michael P Mckenna officer: President and COO C/O CURAGEN CORP, 555 LONG WHARF DR. 11TH FL., NEW HAVEN CT 06511
Patrick Schneider officer: President and COO C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
John Viii Stark director, officer: Chief Executive Officer C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
2012 Jmr Trust Common Llc 10 percent owner C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437